Bifidobacterium is a genus—a group of related bacterial species—found in the human gut. These organisms participate in carbohydrate metabolism. A low stool result describes the assay’s measurement of a group, not a diagnosis of a deficiency that must be corrected with a particular supplement.
On this page
Why Bifidobacterium is studied
Different bifidobacteria use different carbohydrates and interact with other members of the intestinal community. Their metabolic products include acetate and lactate. These biological roles help explain scientific interest, but a total genus count does not measure every species’ function or your production of individual metabolites. [1]
What “low” means on GI-MAP
The result is below the laboratory’s comparison range for its targeted assay. It is not a census of every organism throughout the digestive tract, and below detection is not the same as proving the genus is absent from your body. Sample timing and recent diet, illness or antibiotic exposure belong in the interpretation. [2]
Why a stool count cannot choose a probiotic
A probiotic label may name a species and a particular strain. Those details are more specific than a Bifidobacterium genus result. Evidence for one strain or indication cannot automatically be transferred to another product. Increasing a report number is also not the same as demonstrating a health benefit.
The broader evidence for directing individual care from microbiome-composition results remains limited. Discuss your actual symptoms and goals before making a supplement decision from a low flag. [3]
Common questions
Does low Bifidobacterium explain all my digestive symptoms?
No. The finding is not specific to one condition and cannot establish causation.
Can I compare this with a percentage on another microbiome test?
Not directly. A percentage, a DNA quantity and different laboratory target sets use different measurement systems. Compare like methods and units.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- Bifidobacteria and their role in the human gut microbiota, 2016
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
- International consensus statement on microbiome testing in clinical practice (2025)
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.